Phase I Safety Study of Intratumoural Injection of Clostridium Novyi-NT Spores in Patients With Treatment-refractory Solid Tumour Malignancies
Phase of Trial: Phase I
Latest Information Update: 11 Sep 2019
Price : $35 *
At a glance
- Drugs Clostridium novyi-NT (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors BioMed Valley Discoveries
- 10 May 2018 Status changed from active, no longer recruiting to completed.
- 21 Jun 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jan 2018.
- 21 Jun 2017 Status changed from recruiting to active, no longer recruiting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History